Bioscience Equity Partners (BEP) is a global investment bank, fund manager, and venture capital platform exclusively dedicated to the life-sciences sector. Headquartered across London, New York, Sydney, Bucharest, and the British Virgin Islands, BEP provides end-to-end financial and strategic solutions to biotechnology, med-tech, and digital-health companies.

Through its proprietary Antisoma Venture Capital Fund S.A., BEP invests directly alongside its institutional syndicate, which includes leading sovereign-wealth and corporate-venture investors in the Middle East and Asia. This dual structure allows BEP to act both as investor and investment bank—providing venture capital, equity, and debt financing tailored to accelerate growth, de-risk development, and fast-track value creation.

BEP’s mission is to bridge scientific innovation with institutional capital, empowering visionary founders to reach clinical, commercial, and capital-market milestones.